Covid-19 roundup: Moderna rewrites agreement with Gavi; Bavarian Nordic touts PhII booster results
Moderna is calling it quits on its current agreement with Gavi, the Vaccine Alliance, meaning an original deal for up to 500 million doses of the mRNA vaccine is now out the door.
On Monday, Moderna said it had mutually canceled the supply agreement, with all pending orders axed for the remainder of the year. Through its COVAX work, Gavi said it had delivered nearly 186 million doses of the Moderna vaccine via the advance purchase agreement and donations.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.